ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q907. A total of 3 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $11,955,000 | -78.3% | 941 | -79.9% | 1.09% | -69.7% |
| Q3 2017 | $54,985,000 | +302.2% | 4,680 | +173.0% | 3.59% | +301.9% |
| Q2 2017 | $13,671,000 | +35.7% | 1,714 | -12.8% | 0.89% | +64.6% |
| Q1 2017 | $10,071,000 | +116.9% | 1,965 | +58.5% | 0.54% | +101.1% |
| Q4 2016 | $4,643,000 | -52.7% | 1,240 | -14.4% | 0.27% | -26.6% |
| Q3 2016 | $9,815,000 | +79.2% | 1,448 | +46.7% | 0.37% | +28.7% |
| Q2 2016 | $5,477,000 | -59.3% | 987 | -41.1% | 0.29% | -48.5% |
| Q3 2015 | $13,468,000 | -73.0% | 1,676 | -59.7% | 0.56% | -69.5% |
| Q2 2015 | $49,830,000 | +46.9% | 4,157 | +27.9% | 1.82% | +28.8% |
| Q1 2015 | $33,926,000 | +395.4% | 3,249 | +360.2% | 1.41% | +553.7% |
| Q4 2014 | $6,848,000 | -62.8% | 706 | -70.0% | 0.22% | -69.4% |
| Q3 2014 | $18,393,000 | +2965.5% | 2,355 | +2378.9% | 0.71% | +2615.4% |
| Q2 2014 | $600,000 | -58.6% | 95 | -79.7% | 0.03% | -73.2% |
| Q2 2013 | $1,451,000 | – | 468 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Marathon Trading Investment Management LLC | 3,000 | $437,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 45,100 | $6,567,000 | 0.02% |
| SIMPLEX TRADING, LLC | 340 | $4,950,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |